Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer

Breast cancer (BC) is the most common cause of cancer-related death in women worldwide. Therapies targeting molecular pathways altered in BC had significantly enhanced treatment options for BC over the last decades, which ultimately improved the lives of millions of women worldwide. Among various mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Sobhani, Navid, Fassl, Anne, Mondani, Giuseppina, Generali, Daniele, Otto, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912842/
https://www.ncbi.nlm.nih.gov/pubmed/33535617
http://dx.doi.org/10.3390/cells10020293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912842/
https://www.ncbi.nlm.nih.gov/pubmed/33535617
http://dx.doi.org/10.3390/cells10020293

Ejemplares similares